Stage-Gate Incentive Design in Product Development With Resource Competition Among Parallel Projects
Abstract: Firms often follow the stage-gate process to manage multiple projects in product development and delegate stages of idea discovery and product development to project managers. This framework ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Retail environments demonstrate real performance. When stores introduce LED neon signage, 80% report increases in both foot traffic and sales. Retailers see average sales lifts around 28% in areas ...
Low fruit intake is a global risk factor for cardiometabolic diseases. This study sought to investigate vascular and metabolic effects of increasing total and select fruit intake in adults with ...
3 The Affiliated Guangzhou Hospital of TCM of Guangzhou University of Chinese Medicine, Guangzhou, China 4 The Affiliated Brain Hospital, Guangzhou Medical University, Key Laboratory of Neurogenetics ...
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study This randomized, parallel-group, phase II study ...
A motion control strategy based on multi-source heterogeneous motion information fusion and motion decoupling parallel washout algorithm (WA) is proposed for the control of a rehabilitation robot ...
The idea of a think tank is not new. Traditionally found in politics, economics, or science, think tanks bring together experts to study complex problems and propose solutions. In architecture, their ...
Eclipse combines high-throughput execution with Ethereum settlement in a way no other L2 has attempted. Cointelegraph Research breaks down the architecture and the milestones that will define its ...
If you've been driving for long enough, and particularly if you've had the same car for a long time, you develop a keen instinct for which parking spots will be too much of a squeeze. Parallel parking ...
On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The company cited strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results